Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Shares Outstanding: 2015-2024

Historic Shares Outstanding for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $82.7 million.

  • Editas Medicine's Shares Outstanding rose 12.99% to $93.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.3 million, marking a year-over-year increase of 12.99%. This contributed to the annual value of $82.7 million for FY2024, which is 1.18% up from last year.
  • According to the latest figures from FY2024, Editas Medicine's Shares Outstanding is $82.7 million, which was up 1.18% from $81.8 million recorded in FY2023.
  • Editas Medicine's Shares Outstanding's 5-year high stood at $82.7 million during FY2024, with a 5-year trough of $62.6 million in FY2020.
  • In the last 3 years, Editas Medicine's Shares Outstanding had a median value of $81.8 million in 2023 and averaged $77.8 million.
  • Data for Editas Medicine's Shares Outstanding shows a peak YoY climbed of 18.77% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Editas Medicine's Shares Outstanding stood at $62.6 million in 2020, then climbed by 9.39% to $68.4 million in 2021, then climbed by 0.60% to $68.8 million in 2022, then increased by 18.77% to $81.8 million in 2023, then increased by 1.18% to $82.7 million in 2024.